Teehan Brendan
CIK 0001891900
EVP, COO, Head of Commercial
Filings
22
Latest Feb 13, 2026
Issuers covered
2
Showing
22 of 22
Page 1
Track record
16 of 16 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 16 | 44% | -0.8% | -3.4% | +29.7% | -26.7% |
| 90 days | 16 | 38% | -1.6% | -8.2% | +41.7% | -34.4% |
| 180 days | 16 | 63% | +4.4% | +12.1% | +45.8% | -51.4% |
| 365 days | 16 | 69% | +1.0% | +16.7% | +42.3% | -81.9% |
Issuers
Companies where Teehan Brendan has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| ACAD | Acadia Pharmaceuticals Inc | 18 | Nov 19, 2024 |
| PCRX | Pacira Biosciences, Inc. | 4 | Feb 13, 2026 |
All filings
22 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|